Dimensional Fund Advisors
ZBIO

Dimensional Fund Advisors’s Zenas BioPharma ZBIO Stock Holding History

Dimensional Fund Advisors’s Portfolio ZBIO Stock Details ZBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$225K Buy
+8,874
New +$176K ﹤0.01% 3062

Other funds holding ZBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
RPSM
Royalty Pharma Sub-Manager New York $242M AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return

Dimensional Fund Advisors's ZBIO Position: Q2 2026 in Review

Dimensional Fund Advisors opened a new position in Zenas BioPharma (ZBIO) in Q2 2026: 8,874 shares worth $225K. The stake represents ﹤0.01% of the portfolio and ranks #3062 among its holdings.

145 funds tracked by Wall St. Rank hold ZBIO as of Q2 2026.

  • Dimensional Fund Advisors held 8,874 shares of Zenas BioPharma worth $225K as of Q2 2026.
  • Zenas BioPharma was a new Dimensional Fund Advisors position in Q2 2026.
  • Zenas BioPharma made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q2 2026, its #3062 holding.
  • 145 funds tracked by Wall St. Rank held Zenas BioPharma as of Q2 2026.

Based on Dimensional Fund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.